• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Natera, Inc. - Common Stock (NQ:NTRA)

    265.03 -9.59 (-3.49%)
    Streaming Delayed Price Updated: 3:21 PM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,032,817
    Open 267.71
    Bid (Size) 264.80 (100)
    Ask (Size) 265.27 (200)
    Prev. Close 274.62
    Today's Range 263.55 - 272.37
    52wk Range 134.85 - 288.04
    Shares Outstanding 139,693,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗
    Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 24.85% on an annualized basis producing an average annual return of 38.28%. Currently, Natera has a market capitalization of... 
    Via Benzinga
    News headline image
    Natera Submits Signatera™ to Japan’s PMDA for Approval as a Companion Diagnostic in Muscle-Invasive Bladder Cancer
    From Natera, Inc.
    Via Business Wire

    Performance

    YTD
    +15.8%
    +15.8%
    1 Month
    -6.6%
    -6.6%
    3 Month
    +23.2%
    +23.2%
    6 Month
    +28.9%
    +28.9%
    1 Year
    +89.1%
    +89.1%

    More News

    Read More
    News headline image
    Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings
    Via StockStory
    News headline image
    Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy? ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Natera to Report its Second Quarter Results on August 6, 2026
    From Natera, Inc.
    Via Business Wire
    News headline image
    1 Unpopular Stock That Deserves Some Love and 2 We Question
    Via StockStory
    News headline image
    3 Reasons We’re Fans of Natera (NTRA)
    Via StockStory
    Topics Stocks
    News headline image
    Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study
    From Natera, Inc.
    Via Business Wire
    News headline image
    3 Market-Beating Stocks Worth Your Attention
    Via StockStory
    News headline image
    Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio
    From Natera, Inc.
    Via Business Wire
    News headline image
    Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves. ↗
    Via The Motley Fool
    News headline image
    Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off
    Via StockStory
    News headline image
    Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers
    From Natera, Inc.
    Via Business Wire
    News headline image
    Signatera™ MRD Test Predicted Overall Survival Benefit from Chemotherapy in Resected Metastatic Colorectal Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
    From Natera, Inc.
    Via Business Wire
    News headline image
    Why Natera (NTRA) Stock Is Up Today
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
    From Natera, Inc.
    Via Business Wire
    News headline image
    Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
    From Natera, Inc.
    Via Business Wire
    News headline image
    1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
    Via StockStory
    News headline image
    1 Cash-Heavy Stock on Our Buy List and 2 We Avoid
    Via StockStory
    Topics Retirement
    News headline image
    2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down
    Via StockStory
    News headline image
    Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
    From Natera, Inc.
    Via Business Wire
    News headline image
    Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia) ↗
    Via The Motley Fool

    Frequently Asked Questions

    Is Natera, Inc. - Common Stock publicly traded?
    Yes, Natera, Inc. - Common Stock is publicly traded.
    What exchange does Natera, Inc. - Common Stock trade on?
    Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Natera, Inc. - Common Stock?
    The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
    What is the current price of Natera, Inc. - Common Stock?
    The current price of Natera, Inc. - Common Stock is 265.03
    When was Natera, Inc. - Common Stock last traded?
    The last trade of Natera, Inc. - Common Stock was at 08/06/26 03:21 PM ET
    What is the market capitalization of Natera, Inc. - Common Stock?
    The market capitalization of Natera, Inc. - Common Stock is 37.02B
    How many shares of Natera, Inc. - Common Stock are outstanding?
    Natera, Inc. - Common Stock has 37B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.